Cancer treatment investment boost for Dundee University

Cancer treatment could be boosted by a €2 million project funded by the European Union that aims to bring together the latest innovation in anti-cancer technologies.

The Nanoporation project brings together the companies InSightec and CapsuTech, and is based at the University of Dundee.

Taking place over the course of four years, the initiative is designed to devise less invasive cancer treatment that produces fewer side-effects.

Professor Andreas Melzer, director of the Institute for Medical Science and Technology (IMSaT) at the University of Dundee, commented: "All of the established methods of cancer treatment have significant drawbacks, in that they cause side effects, require invasive procedures or do not deliver their therapeutic effect in an effective manner."

He added that by bringing together ultrasound, MRI and nano-capsules technologies, combined with micro-bubbles, cancer-defeating drugs that had already been proven to work could be administered to specific areas.

MRI is magnetic resonance imaging and is used in radiology to create an internal image of the body.

Comment on this page »


Latest news

Spire Harpenden Hospital wins prestigious industry award

New testing technique comes to The Royal Marsden

Bupa announce £2.9 million investment

Cancer treatment investment boost for Dundee University
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information